<p>Atrial fibrillation (AF) is more prevalent in patients with elevated interleukin (IL)-1β levels. Here we show that daily administration of IL-1β for 15 days sensitizes mice to AF, leading to fibrosis, accumulation of β-pleated sheet proteins in the left atrium, and systemic inflammation, resembling the pathophysiological changes observed in patients with AF. IL-1β administration creates a positive feedback loop, dependent on the IL-1 receptor (IL-1R) activity in cardiac resident macrophages. This results in increased caspase-1 maturation in the left atrium and elevated <i>Il1b</i> and <i>Casp1</i> transcription in atrial macrophages. IL-1β treatment accelerated action potential and Ca<sup>2+</sup> restitution in the left atrium, leading to action-potential shortening. This, along with increased caspase-1 maturation and IL-1R signaling, was essential for inducing AF. Lack of IL-1R in macrophages, but not cardiomyocytes, prevented IL-1β-induced AF sensitivity. By depleting recruited macrophages or deleting IL-1R specifically in cardiac resident macrophages, we further demonstrate that IL-1β/IL-1R signaling in these resident macrophages is responsible for increased AF susceptibility. These findings offer insights into the therapeutic potential of targeting IL-1β/IL-1R signaling in patients with AF and emphasize the importance of recognizing different underlying causes in this patient group.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

IL-1β enhances susceptibility to atrial fibrillation in mice by acting through resident macrophages and promoting caspase-1 expression

  • Oscar Moreno-Loaiza,
  • Vinicius Cardoso Soares,
  • Manuela de Assumpção Souza,
  • Narendra Vera-Nuñez,
  • Ainhoa Rodriguez de Yurre Guirao,
  • Tatiana Pereira da Silva,
  • Ana Beatriz Pozes,
  • Larissa Perticarrari,
  • Evelin Monteiro,
  • Maria Clara Albino,
  • Sophia Barros Silva,
  • Suelen Silva Gomes Dias,
  • Leonardo Maciel,
  • Humberto Muzi-Filho,
  • Dahienne Ferreira de Oliveira,
  • Bruno Cabral Braga,
  • Luan Pereira Diniz,
  • Mario Costa Cruz,
  • Simone Reis Barbosa,
  • Archimedes Barbosa Castro-Junior,
  • Luciana Conde,
  • Mauro Jorge Cabral-Castro,
  • Olga Ferreira de Souza,
  • Martha Valéria Tavares Pinheiro,
  • Nilson Araújo de Oliveira Junior,
  • Leonardo Rezende de Siqueira,
  • Rodrigo Periquito Cosenza,
  • Claudio Munhoz da Fontoura,
  • Jose Carlos Pizzolante Secco,
  • Juliana da Rocha Ferreira,
  • Andréa Silvestre de Sousa,
  • Denilson Albuquerque,
  • Ronir Raggio Luiz,
  • Pedro Nicolau-Neto,
  • Marco Antonio Pretti,
  • Mariana Boroni,
  • Martin Hernán Bonamino,
  • Tais Hanae Kasai-Brunswick,
  • Debora Bastos Mello,
  • Triciana Gonçalves-Silva,
  • Isalira Peroba Ramos,
  • Fernando A. Bozza,
  • João Paulo do Vale Madeiro,
  • Roberto Coury Pedrosa,
  • Marcela Sorelli Carneiro-Ramos,
  • Herculano da Silva Martinho,
  • Patrícia T. Bozza,
  • Fernanda Mesquita de Souza,
  • Gabriel Victor Lucena da Silva,
  • Thiago M. Cunha,
  • Ilija Uzelac,
  • Flavio Fenton,
  • Renata Moll-Bernardes,
  • Claudia N. Paiva,
  • Ariel L. Escobar,
  • Emiliano Medei

摘要

Atrial fibrillation (AF) is more prevalent in patients with elevated interleukin (IL)-1β levels. Here we show that daily administration of IL-1β for 15 days sensitizes mice to AF, leading to fibrosis, accumulation of β-pleated sheet proteins in the left atrium, and systemic inflammation, resembling the pathophysiological changes observed in patients with AF. IL-1β administration creates a positive feedback loop, dependent on the IL-1 receptor (IL-1R) activity in cardiac resident macrophages. This results in increased caspase-1 maturation in the left atrium and elevated Il1b and Casp1 transcription in atrial macrophages. IL-1β treatment accelerated action potential and Ca2+ restitution in the left atrium, leading to action-potential shortening. This, along with increased caspase-1 maturation and IL-1R signaling, was essential for inducing AF. Lack of IL-1R in macrophages, but not cardiomyocytes, prevented IL-1β-induced AF sensitivity. By depleting recruited macrophages or deleting IL-1R specifically in cardiac resident macrophages, we further demonstrate that IL-1β/IL-1R signaling in these resident macrophages is responsible for increased AF susceptibility. These findings offer insights into the therapeutic potential of targeting IL-1β/IL-1R signaling in patients with AF and emphasize the importance of recognizing different underlying causes in this patient group.